𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progression and treatment of HER2-positive breast cancer

✍ Scribed by April Davoli; Barbara A. Hocevar; Thomas L. Brown

Publisher
Springer
Year
2009
Tongue
English
Weight
406 KB
Volume
65
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Targeting chromosomal instability and tu
Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer
✍ Rebecca A. Burrell; Nicolai Juul; Stephen R. Johnston; Jorge S. Reis-Filho; Zolt πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 181 KB

## Abstract Chromosomal instability (CIN) is a common cause of tumour heterogeneity and poor prognosis in solid tumours and describes cell–cell variation in chromosome structure or number across a tumour population. In this article we consider evidence suggesting that CIN may be targeted and may in

Cost-effectiveness analysis of trastuzum
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer
✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 209 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t